tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Buy Rating for Legend Biotech Reaffirmed Due to CARVYKTI’s Strong Market Position and Proven Efficacy
PremiumRatingsBuy Rating for Legend Biotech Reaffirmed Due to CARVYKTI’s Strong Market Position and Proven Efficacy
2M ago
Legend Biotech price target raised to $75 from $66 at Cantor Fitzgerald
Premium
The Fly
Legend Biotech price target raised to $75 from $66 at Cantor Fitzgerald
2M ago
Legend Biotech price target lowered to $90 from $94 at Barclays
Premium
The Fly
Legend Biotech price target lowered to $90 from $94 at Barclays
2M ago
Legend Biotech Reports Strong Q3 2025 Results and CARVYKTI® Progress
PremiumCompany AnnouncementsLegend Biotech Reports Strong Q3 2025 Results and CARVYKTI® Progress
2M ago
Legend Biotech reports Q3 adjusted EPS (5c), consensus (12c)
Premium
The Fly
Legend Biotech reports Q3 adjusted EPS (5c), consensus (12c)
2M ago
Legend Biotech sees cash runway beyond 2026
Premium
The Fly
Legend Biotech sees cash runway beyond 2026
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100